Pierre-Marie Wardyn1, Virginie de Broucker1,2, Cécile Chenivesse3,4,5, Annie Sobaszek2,6, Richard Van Bulck1, Thierry Perez1,4, Jean-Louis Edmé1,2, Sébastien Hulo1,2. 1. Service des Explorations Fonctionnelles Respiratoires, CHU Lille, Lille, France. 2. EA 4483-IMPECS-IMPact de l'Environnement Chimique sur la Santé humaine, Univ. Lille, Lille, France. 3. Service de Pneumologie et Immuno-Allergologie, Centre de Référence Constitutif des Maladies Pulmonaires Rares, CHU Lille, Lille, France. 4. INSERM U1019-CNRS UMR 8204, Institut Pasteur de Lille-CIIL-Center for Infection and Immunity of Lille, Lille, France. 5. Univ. Lille, Lille, France. 6. Service de Médecine du Travail, CHU Lille, Lille, France.
Abstract
BACKGROUND: The single-breath diffusing capacity of the lung for carbon monoxide (DLCO) interpretation needs the comparison of measured values to reference values. In 2017, the Global Lung Function Initiative published new reference values (GLI-2017) for DLCO, alveolar volume (VA) and transfer coefficient of the lung for carbon monoxide (KCO). We aimed to assess the applicability of GLI-2017 reference values for DLCO on a large population by comparing them to the European Community of Steel and Coal equations of 1993 (ECSC-93) widely used. METHODS: In this retrospective study, spirometric indices, total lung capacity, DLCO, VA and KCO were measured in adults classified in 5 groups (controls, asthma, chronic bronchitis, cystic fibrosis, and interstitial lung diseases (ILD)). Statistical analysis comparing the 2 equations sets were stratified by sex. RESULTS: 4180 tests were included. GLI-2017 z-scores of the 3 DLCO indices of the controls (n = 150) are nearer to 0 (expected value in a normal population) than ECSC-93 z-scores. All groups combined, in both genders, DLCO GLI-2017 z-scores and %predicted are significantly higher than ECSC z-scores and %predicted. In the ILD group, differences between the 2 equation sets depend on the DLCO impairment severity: GLI-2017 z-scores are higher than ECSC z-scores in patients with no or "mild" decrease in DLCO, but are lower in "moderate" or "severe" decrease. CONCLUSION: GLI-2017 reference values for DLCO are more suitable to our population and influence the diagnostic criteria and severity definition of several lung diseases.
BACKGROUND: The single-breath diffusing capacity of the lung for carbon monoxide (DLCO) interpretation needs the comparison of measured values to reference values. In 2017, the Global Lung Function Initiative published new reference values (GLI-2017) for DLCO, alveolar volume (VA) and transfer coefficient of the lung for carbon monoxide (KCO). We aimed to assess the applicability of GLI-2017 reference values for DLCO on a large population by comparing them to the European Community of Steel and Coal equations of 1993 (ECSC-93) widely used. METHODS: In this retrospective study, spirometric indices, total lung capacity, DLCO, VA and KCO were measured in adults classified in 5 groups (controls, asthma, chronic bronchitis, cystic fibrosis, and interstitial lung diseases (ILD)). Statistical analysis comparing the 2 equations sets were stratified by sex. RESULTS: 4180 tests were included. GLI-2017 z-scores of the 3 DLCO indices of the controls (n = 150) are nearer to 0 (expected value in a normal population) than ECSC-93 z-scores. All groups combined, in both genders, DLCO GLI-2017 z-scores and %predicted are significantly higher than ECSC z-scores and %predicted. In the ILD group, differences between the 2 equation sets depend on the DLCO impairment severity: GLI-2017 z-scores are higher than ECSC z-scores in patients with no or "mild" decrease in DLCO, but are lower in "moderate" or "severe" decrease. CONCLUSION: GLI-2017 reference values for DLCO are more suitable to our population and influence the diagnostic criteria and severity definition of several lung diseases.
Authors: R Pellegrino; G Viegi; V Brusasco; R O Crapo; F Burgos; R Casaburi; A Coates; C P M van der Grinten; P Gustafsson; J Hankinson; R Jensen; D C Johnson; N MacIntyre; R McKay; M R Miller; D Navajas; O F Pedersen; J Wanger Journal: Eur Respir J Date: 2005-11 Impact factor: 16.671
Authors: J Wanger; J L Clausen; A Coates; O F Pedersen; V Brusasco; F Burgos; R Casaburi; R Crapo; P Enright; C P M van der Grinten; P Gustafsson; J Hankinson; R Jensen; D Johnson; N Macintyre; R McKay; M R Miller; D Navajas; R Pellegrino; G Viegi Journal: Eur Respir J Date: 2005-09 Impact factor: 16.671
Authors: M R Miller; J Hankinson; V Brusasco; F Burgos; R Casaburi; A Coates; R Crapo; P Enright; C P M van der Grinten; P Gustafsson; R Jensen; D C Johnson; N MacIntyre; R McKay; D Navajas; O F Pedersen; R Pellegrino; G Viegi; J Wanger Journal: Eur Respir J Date: 2005-08 Impact factor: 16.671
Authors: Monique Wapenaar; Jelle R Miedema; Catharina J Lammering; Frans W Mertens; Marlies S Wijsenbeek Journal: Eur Respir J Date: 2019-01-31 Impact factor: 16.671
Authors: Brian L Graham; Vito Brusasco; Felip Burgos; Brendan G Cooper; Robert Jensen; Adrian Kendrick; Neil R MacIntyre; Bruce R Thompson; Jack Wanger Journal: Eur Respir J Date: 2017-01-03 Impact factor: 16.671
Authors: Emily S Wan; Spyridon Fortis; Elizabeth A Regan; John Hokanson; MeiLan K Han; Richard Casaburi; Barry J Make; James D Crapo; Dawn L DeMeo; Edwin K Silverman Journal: Am J Respir Crit Care Med Date: 2018-12-01 Impact factor: 30.528
Authors: Ivan Cherrez-Ojeda; Efraín Sanchez-Angarita; Emanuel Vanegas; María J Farfán Bajaña; Karla Robles-Velasco; María F Osorio; Azza Sarfraz; Zouina Sarfraz; Juan C Calderón; Jorge Cáneva; Laura Gochicoa-Rangel; Matías P Lascano; Juan C Fernández Cadena; Derly M Andrade Molina; Amado X Freire; Miguel Felix Journal: J Community Hosp Intern Med Perspect Date: 2022-04-12
Authors: Kevin De Soomer; Evelyn Pauwels; Hilde Vaerenberg; Eric Derom; Lidia Casas; Johan Verbraecken; Thérèse Lapperre; Ellie Oostveen Journal: ERJ Open Res Date: 2022-06-13